¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"bone tumour"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • reticulofibrous membrane bone
    ¼¼¸Á¼¶À¯¸·»À, ÀÏÂ÷¸·»À
  • solitary bone cyst
    ´ÜÀÏ»À³¶Á¾, °í¸³°ñ³¶Á¾
  • sphenoid bone
    ³ªºñ»À, Á¢Çü°ñ
  • scaphoid bone
    ¼Õ¹è»À, ÁÖ»ó°ñ
  • spongy bone
    °¹¼Ø»À, ÇØ¸é°ñ
  • substitution bone
    ´ë¿ë»À
  • supernumerary bone
    °úÀ×»À, °úÀ×°ñ
  • sutural bone
    ºÀÇÕ»À
  • sesamoid bone
    Á¾ÀÚ»À
  • short bone
    ªÀº»À, ´Ü°ñ
  • simple bone cyst
    ´Ü¼ø»À³¶Á¾, °í¸³¼º°ñ³¶Á¾
  • skull bone defect
    ¸Ó¸®»À°á¼Õ, µÎ°³°ñ°á¼Õ
  • temporal bone
    °üÀÚ»À, ÃøµÎ°ñ
  • tarsal bone
    ¹ß¸ñ»À, Á·±Ù°ñ
  • vascularized bone flap
    Ç÷°ü»ÀÆÇ, Ç÷°üÈ­°ñÇÇÆÇ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • tarsal bone
    ¹ß¸ñ»À
  • temporal bone
    °üÀÚ»À
  • trapezium bone
    Å«¸¶¸§»À
  • trapezoid bone
    ÀÛÀº¸¶¸§»À
  • triangular bone
    (¢¡triquetral bone) ¼¼¸ð»À
  • triquetral bone
    ¼¼¸ð»À
  • turbinate bone
    (¢¡nasal concha) ÄÚ¼±¹Ý
  • woven bone
    ¹«Ãþ»À
  • zygomatic bone
    ±¤´ë»À
  • cantilever bone graft
    µé¸²»ÀÀ̽Ä
  • cranial bone flap
    ¸Ó¸®»ÀÇÇÆÇ(¼ú), µÎ°³°ñÇÇÆÇ
  • periosteal bone collar
    »À¸·»À°í¸®
  • marble bone disease
    (¢¡osteopetrosis) »À´ë¸®¼®Áõ, °ñÈ­¼®Áõ
  • skull bone defect
    ¸Ó¸®»À°á¼Õ, µÎ°³°ñ°á¼Õ
  • reactive bone excrescence
    ¹ÝÀÀ»Àµ¹Ãâ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • bone marrow transplantation
    °ñ¼öÀ̽Ä
  • bone marrow transplantation
    °ñ¼öÀ̽Ä(¼ú)(?ËöËàËà).
  • bone marrow transplantation
    °ñ¼öÀ̽Ä(¼ú)(¡­ì¹ãÕâú).
  • bone marrow-derived cell
    °ñ¼öÀ¯·¡¼¼Æ÷
  • bone matrix
    »À ±âÁú, °ñ ±âÁú(ÍéÐñòõ).
  • bone matrix
    »À±âÁú, °ñ±âÁú(ÍéÐñòõ).
  • bone matrix
    »À¹ÙÅÁÁú
  • bone meal
    »À °¡·ç, °ñ ºÐ(ÍéÝÏ).
  • bone metastasis
    °ñ ÀüÀÌ (Íéï®ì¹) ¡ì¾ÏÀÇ¡í.
  • bone metastasis
    °ñÀüÀÌ (Íéï®ì¹) ¡ì¾ÏÀÇ¡í.
  • bone mineral metabolism
    °ñ ¹«±âÁú ´ë»ç(ÍéÙíѦòõÓÛÞó), °ñ ±¤¹°(Áú) ´ë»ç.
  • bone mineral metabolism
    °ñ±¤¹°(Áú)´ë»ç.
  • bone of lower limb
    ÇÏÁö»À, ÇÏÁö°ñ(ù»ò¶Íé).
  • bone of upper limb
    »óÁö»À, »óÁö°ñ (ß¾ò¶Íé).
  • bone onlay
    °ñ ¿ÜÀç(Íéèâî¤), ¿ÜÀç °ñ(èâî¤Íé), °ñ ÀÌ½ÄÆí(Íéì¹ãÕø¸).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
BRF bone-resorbing factor
BRU bone remodeling unit
CaBI calcium bone index
FAR Federal acquisitions regulation; fractional albumin rate; fresh bone marrow
HBD has been drinking; hydroxybutyric dehydrogenase; hypophosphatemic bone disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
BMC Bone Mineral Content
BMD Bone Mineral Density
BMP Bone Morphogenetic Protein
BMP-2 Bone Morphogenetic Protein 2
BMP-4 Bone Morphogenetic Protein 4
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mastoid bone
    À¯¾ç °ñ
  • maxillary bone
    »ó¾Ç°ñ
  • medullary bone
    ¼öÁú°ñ
  • metabolic bone disease
    ´ë»ç¼º °ñ Áúȯ
  • metastatic bone tumor
    ÀüÀ̼º °ñ Á¾¾ç
  • nasal bone
    ºñ°ñ
    ÄàµîÀ» Çü¼ºÇÏ´Â µÎ °³ÀÇ À广Çü »À Áß Çϳª.
  • nasal process of the frontal bone
    ÀüµÎ°ñ ºñºÎ
  • nonlamellar bone
    ºñÃþÆÇ°ñ
  • nonossified bone
    ºñ¼®È­µÈ °ñ
  • onlay bone graft
    ÁßÃþ°ñ ÀÌ½ÄÆí
    ÇÇÀ̽ÄÀÚÀÇ ÇÇÁú¼º °ñ À§¿¡ µ¤´Â ÀÌ½ÄÆíÀ¸·Î¼­ÀÇ »À.
  • palate bone
    ±¸°³°ñ
    µÎ°³°ñÀÇ Çϳª·Î »ó¾Ç°ñ°ú Á¢Çü°ñ¿¡ ³¢¾î °æ±¸°³ ÈÄºÎ¿Í ºñ°­ Ãøº® Èĺθ¦ ¸¸µé¸ç Á¿ì ÇÑ ½ÖÀÌ ÀÖ´Ù.
  • periosteal bone
    °ñ¸· °ñ, °ñ¸·¼º °ñ
  • periosteal bone ring
    °ñ¸· °ñȯ
  • periosteal new bone
    °ñ¸·¼º ½Å»ý°ñ
  • pisiform bone
    µÎ»ó°ñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
pregnancy tumour A pyogenic granuloma developing on the gingiva during pregnancy; thought to be related to hormonally altered response of the oral mucous membranes to local irritants such as bacterial plaque on adjacent teeth.
Synonym: pregnancy tumour.
(05 Mar 2000)
primary brain tumour <neurology, oncology> May be subdivided into primary brain tumours and the more common, secondary brain tumours.
Primary brain tumours (for example astrocytoma, craniopharyngioma, glioma, ependymoma, neuroglioma, oligodendroglioma, glioblastoma multiforme, meningioma, medulloblastoma) arise from the uncontrolled proliferation of cells within the brain.
Secondary brain tumours occur from the spread of cancer into the brain from a distant cancerous organ (metastasis).
Common symptoms of a brain tumour include headache, nausea, vomiting, seizures, change in mentation, neurologic symptoms and loss of memory.
(06 Mar 1998)
primary tumour <oncology> The mass of tumour cells at the original site of the neoplastic event from the primary tumour metastasis will lead to the establishment of secondary tumours.
(18 Nov 1997)
primitive neuroectodermal tumour A designation used to refer to a group of morphologically similar embryonal neoplasms that arise in intracranial and peripheral sites of the nervous system and which may show various degrees of cellular differentiation; includes medulloblastoma, pineoblastoma, etc.
(05 Mar 2000)
sand tumour <tumour> A firm cellular neoplasm derived from fibrous tissue of the meninges, choroid plexus, and certain other structures associated with the brain, characterised by the formation of multiple, discrete, concentrically laminated, calcareous bodies (psammoma bodies); most of these neoplasms are histologically benign, but may lead to severe symptoms as a result of compressing the brain.
Synonym: angiolithic sarcoma, sand tumour, Virchow's psammoma.
(05 Mar 2000)
heterologous tumour A tumour composed of a tissue unlike that from which it springs.
(05 Mar 2000)
hilar cell tumour of ovary A small benign masculinizing ovarian tumour derived from hilar cells, which resemble Leydig cells of the testis.
(05 Mar 2000)
histoid tumour Old term for a tumour composed of a single type of differentiated tissue.
(05 Mar 2000)
secondary tumour <oncology> A tumour that develops as a result of metastasis or spreads beyond the original cancer.
(09 Oct 1997)
homologous tumour <oncology> Any tumour which is composed of the same tissue as that in which it arose.
(09 Oct 1997)
Hurthle cell tumour A neoplasm of the thyroid gland composed of polyhedral acidophilic cells, thought by some to be oncocytes; it may be benign or malignant, the behaviour of the latter depending on the general microscopic pattern, whether follicular, papillary, or undifferentiated.
See: Hurthle cell adenoma.
Synonym: Hurthle cell carcinoma.
(05 Mar 2000)
sertoli cell tumour A rare benign tumour of the testis that histologically resembles the foetal testis. There are three varieties: diffuse stromal, mixed (stromal and epithelial), and tubular (epithelial). Sertoli cells in the epithelial elements may produce oestrogen and cause feminization.
(12 Dec 1998)
sertoli-leydig cell tumour An ovarian tumour usually of low-grade malignancy occurring most frequently in the third and fourth decades, with 75% seen in women under 40. It is rare, representing less than .02% of ovarian cancers. The tumour typically produces androgens with virilization being noted in 70-85% of the patients. (holland et al., cancer medicine, 3d ed, p1684)
(12 Dec 1998)
sex cord-stromal tumour A malignant neoplasm of the ovary or testis. These tumours differentiate toward sex cords (in embryonic gonads) in the form of female (i.e., granulosa and theca) cells, male (i.e., sertoli and leydig) cells, or indifferent elements. In the ovary, sex cord-stromal tumours comprise 5% of all ovarian neoplasms. In the testes, leydig and sertoli cell tumours comprise about 5% of all testicular neoplasms, 10% of which behave in a malignant fashion.
(12 Dec 1998)
hylic tumour <tumour> A neoplasm of pulp tissue, resulting from proliferation of elements derived from the embryonic pulp of epiblastic origin.
Synonym: hylic tumour.
Origin: G. Hyle, stuff, crude matter, + -oma, tumour
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á